Infinity Pharmaceuticals, Inc. (INFI)
INFI Stock Chart More Charts
INFI Price/Volume Stats
| Current price | $1.84 |
| Prev. close | $1.72 |
| Day low | $1.70 |
| Day high | $1.84 |
| 50-day MA | $2.05 |
| 200-day MA | $1.99 |
| 52-week high | $3.75 |
| 52-week low | $0.93 |
| Volume | 546,400 |
| Avg. volume | 657,628 |
| Dividend yield | N/A |
| Market Cap | 103.17M |
INFI Returns
| 1-mo | -7.54% |
| 3-mo | -26.69% |
| 6-mo | 0.00% |
| 1-year | 8.24% |
| 3-year | -83.96% |
| 5-year | -90.10% |
| YTD | -9.36% |
| 2017 | 50.37% |
| 2016 | -82.80% |
| 2015 | -53.52% |
| 2014 | 22.30% |
| 2013 | -60.54% |
Infinity Pharmaceuticals, Inc. (INFI) Company Bio
Infinity Pharmaceuticals, Inc. discovers, develops, and delivers medicines to patients with difficult-to-treat diseases. Its lead product candidate includes IPI-145, an oral inhibitor of the delta and gamma isoforms of phosphoinositide-3-kinase (PI3K) for the treatment of hematologic malignancies. The company was founded in 2001 and is based in Cambridge, Massachusetts.
Loading social stream, please wait...